Similar articles for PMID: 30096275

Year	Number of Results
1967	1
1987	1
1997	1
2005	1
2008	1
2009	7
2011	1
2012	5
2013	5
2014	12
2015	8
2016	14
2017	16
2018	18
2019	2
2020	5
2021	3
2024	0

1

Small Bowel Neuroendocrine Tumors: Big Advances in the Land of Small Tumors.

Singh S, Chan DL. Singh S, et al. J Oncol Pract. 2018 Aug;14(8):485-486. doi: 10.1200/JOP.18.00392. J Oncol Pract. 2018. PMID: 30096275 No abstract available.

2

Progress in the Evaluation and Treatment of Small Bowel Neuroendocrine Tumors.

Mulvey CK, Bergsland EK. Mulvey CK, et al. J Oncol Pract. 2018 Aug;14(8):487-489. doi: 10.1200/JOP.18.00440. J Oncol Pract. 2018. PMID: 30096272 No abstract available.

3

Synchronous small bowel neuroendocrine tumour and lymphoma in a centenarian.

Srikumar G, Gunawardene A, Kodeda K. Srikumar G, et al. ANZ J Surg. 2020 Dec;90(12):2581-2583. doi: 10.1111/ans.15952. Epub 2020 May 2. ANZ J Surg. 2020. PMID: 32359197 No abstract available.

4

[Gastroenteropancreatic neuroendocrine tumors. Editorial].

Díaz Pérez JA. Díaz Pérez JA. Endocrinol Nutr. 2009 Apr;56 Suppl 2:1. doi: 10.1016/S1575-0922(09)70857-5. Epub 2009 May 18. Endocrinol Nutr. 2009. PMID: 19627762 Spanish. No abstract available.

5

Re-evaluating resection of primary pancreatic neuroendocrine tumors.

Pommier RF. Pommier RF. Surgery. 2019 Mar;165(3):557-558. doi: 10.1016/j.surg.2018.11.002. Epub 2018 Dec 17. Surgery. 2019. PMID: 30573190 No abstract available.

6

ASO Author Reflections: Heterogeneity of Duodenal Neuroendocrine Tumors.

Massironi S, Rossi RE. Massironi S, et al. Ann Surg Oncol. 2018 Dec;25(Suppl 3):858-859. doi: 10.1245/s10434-018-6713-1. Epub 2018 Aug 25. Ann Surg Oncol. 2018. PMID: 30145647 No abstract available.

7

Classification of neuroendocrine tumors.

Klöppel G. Klöppel G. Verh Dtsch Ges Pathol. 1997;81:111-7. Verh Dtsch Ges Pathol. 1997. PMID: 9474861 Review.

8

Should we lose hope in adjuvant therapy for neuroendocrine tumors?-In response to: Adjuvant therapy following resection of gastroenteropancreatic neuroendocrine tumors provides no recurrence or survival benefit.

Lamberti G, Manuzzi L, Maggio I, Campana D. Lamberti G, et al. J Surg Oncol. 2020 Sep;122(3):570-571. doi: 10.1002/jso.25969. Epub 2020 Jun 10. J Surg Oncol. 2020. PMID: 32519754 No abstract available.

9

Letter to the editor: Multidisciplinary management of pancreatic neuroendocrine tumors--the importance of an aggressive surgical approach.

Labori KJ, Haugvik SP, Line PD. Labori KJ, et al. Scand J Gastroenterol. 2016 Mar;51(3):383-4. doi: 10.3109/00365521.2015.1094125. Epub 2015 Oct 12. Scand J Gastroenterol. 2016. PMID: 26458136 No abstract available.

10

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas.

Garcia-Carbonero R, Sorbye H, Baudin E, Raymond E, Wiedenmann B, Niederle B, Sedlackova E, Toumpanakis C, Anlauf M, Cwikla JB, Caplin M, O'Toole D, Perren A; Vienna Consensus Conference participants. Garcia-Carbonero R, et al. Neuroendocrinology. 2016;103(2):186-94. doi: 10.1159/000443172. Epub 2016 Jan 5. Neuroendocrinology. 2016. PMID: 26731334 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

91 results

Results by year